PRL and breast carcinoma: Stat5 activation initiates cell differentiation through expression of the CDH-1-β-catenin complex [76, 77], which may suggest a protective effect of PRL against neoplasm formation, because decreased Stat5a activation was associated with metastatic progression in human breast cancer [78].